Targeting Retinal Neurogliovascular Injury: Mechanisms and Therapeutic Strategies

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 185

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cellular Biology and Anatomy, Department of Ophthalmology, Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, USA
Interests: retinal neurovascular injury; diabetic retinopathy; retinopathy of prematurity; inflammation; vascular biology; angiogenesis; ischemia; arginase pathway; nitric oxide
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Medicine, Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, USA
Interests: optic neuropathy; ocular hypertension; ischemic retinopathy; retinal neovascularization; neurodegeneration; neuroinflammation

Special Issue Information

Dear Colleagues,

The retina, with its exquisite neurovascular unit, is uniquely vulnerable to insults that disrupt the intricate balance between neurons, glia, and blood vessels. Injury to this unit is a central pathological feature of major blinding diseases, including diabetic retinopathy, age-related macular degeneration, retinal vein occlusions, and glaucoma. While historically viewed as separate vascular or neuronal disorders, a paradigm shift recognizes these conditions as manifestations of coupled neurovascular injury, where pathological crosstalk between compromised vessels, inflamed glia, and degenerating neurons drives a vicious cycle of disease progression.

This Special Issue, “Targeting Retinal Neurogliovascular Injury: Mechanisms and Therapeutic Strategies”, seeks to compile cutting-edge research and insightful reviews that illuminate the complex, multifactorial mechanisms underlying this injury nexus. We invite contributions exploring novel pathways involving oxidative stress, neuroinflammation, glutamate excitotoxicity, mitochondrial dysfunction, and the breakdown of the blood–retinal barrier. A key focus will be on the dynamic roles of microglia, astrocytes, and pericytes in health and disease.

Furthermore, we emphasize translational and therapeutic research. Both original research articles and high-quality reviews are welcomed on innovative strategies, including novel pharmacologic agents (e.g., neuroprotectants, anti-inflammatories), gene and cell-based therapies, advanced drug delivery systems, and biomarker discovery aimed at halting or reversing neurovascular damage. By integrating mechanistic insights with therapeutic innovation, this Special Issue aims to foster a deeper understanding and inspire new, targeted interventions to preserve vision in retinal diseases.

Prof. Dr. Ruth B. Caldwell
Dr. Syed A. H. Zaidi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • retinal neurogliovascular injury
  • retinal neurogliovascular disease
  • mechanisms
  • therapeutic strategies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop